CoChat

Human retinal ganglion cell neurons generated by synchronous BMP inhibition and transcription factor mediated reprogramming

Agarwal, Devansh, Dash, Nicholas, Mazo, Kevin W., Chopra, Manan, Avila, Maria P., Patel, Amit, Wong, Ryan M., Jia, Cairang, Do, Hope, Cheng, Jie, Chiang, Colette, Jurlina, Shawna L., Roshan, Mona, Perry, Michael W., Rho, Jong M., Broyer, Risa, Lee, Cassidy D., Weinreb, Robert N., Gavrilovici, Cezar, Oesch, Nicholas W., Welsbie, Derek S., Wahlin, Karl J. · 2023 · npj Regenerative Medicine
Cited by 21

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

In optic neuropathies, including glaucoma, retinal ganglion cells (RGCs) die. Cell transplantation and endogenous regeneration offer strategies for retinal repair, however, developmental programs required for this to succeed are incompletely understood. To address this, we explored cellular reprogramming with transcription factor (TF) regulators of RGC development which were integrated into human pluripotent stem cells (PSCs) as inducible gene cassettes. When the pioneer factor NEUROG2 was combined with RGC-expressed TFs ( ATOH7 , ISL1, and POU4F2 ) some conversion was observed and when pre-patterned by BMP inhibition, RGC-like induced neurons (RGC-iNs) were generated with high efficiency in just under a week. These exhibited transcriptional profiles that were reminiscent of RGCs and exhibited electrophysiological properties, including AMPA-mediated synaptic transmission. Additionally, we demonstrated that small molecule inhibitors of DLK/LZK and GCK-IV can block neuronal death in two pharmacological axon injury models. Combining developmental patterning with RGC-specific TFs thus provided valuable insight into strategies for cell replacement and neuroprotection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41536-023-00327-x

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Vector design for insertion of a Tet-On regulated RGC cassette. a A conceptual diagram for a 3G Tet-ON system where doxycycline binds to constitutively expressed rtTA to induce polycistronic expression of NEUROG2, ATOH7, ISLET1, and POU4F2 (NAIP2) leading to conversion of RGC-like neurons. b Electroporation approach for the transient transfection of the NAIP2 transgene package. c PSCs that were transiently transfected with control (empty) or d NAIP2 plasmids and treated with dox for 3 days. Black arrows = PSCs, white arrows = converted neurons. Brightfield and fluorescent images of e the POU4F2-tdTomato+ reporter in a 66-day-old retinal organoid in the IMR90.4 genetic background and f a 65-day-old POU4F2-h2b-mNeonGreen+ retinal organoid in the WA09 genetic background. g U6 promoter-driven expression of an AsCas12a cRNA targeting the CLYBL safe harbor site for insertion of a zeocin selectable Tet-inducible transgene cassette. Scale c, d = 100 µm, e, f = 400 µm.
Fig. 1 Vector design for insertion of a Tet-On regulated RGC cassette. a A conceptual diagram for a 3G Tet-ON system where doxycycline binds to constitutively expressed rtTA to induce polycistronic expression of NEUROG2, ATOH7, ISLET1, and POU4F2 (NAIP2) leading to conversion of RGC-like neurons. b Electroporation approach for the transient transfection of the NAIP2 transgene package. c PSCs that were transiently transfected with control (empty) or d NAIP2 plasmids and treated with dox for 3 days. Black arrows = PSCs, white arrows = converted neurons. Brightfield and fluorescent images of e the POU4F2-tdTomato+ reporter in a 66-day-old retinal organoid in the IMR90.4 genetic background and f a 65-day-old POU4F2-h2b-mNeonGreen+ retinal organoid in the WA09 genetic background. g U6 promoter-driven expression of an AsCas12a cRNA targeting the CLYBL safe harbor site for insertion of a zeocin selectable Tet-inducible transgene cassette. Scale c, d = 100 µm, e, f = 400 µm.CC BY · PubMed Central
Fig. 2 Enhancement of neuronal morphology after patterning by BMP inhibition. a Timeline of LDN193189 and/or dox treatments of POU4F2-tdTomato PSCs with an integrated empty cassette (control) or NAIP2 cassette (conditions 1–3). Brightfield images of dox treated b empty cassette control cells, c NAIP2-nc, d NEUROG2, e POU4F2, f ATOH7, and g ISLET1 cells after 6 days. NAIP2-nc = not clonally selected. h Quantification of %POU4F2+ cells at day 6 relative to DAPI in the empty cassette control and conditions 1–3 illustrated in (a). *P < 0.05, **P < 0.01, ***P < 0.001, ns P > 0.05, n = 3. Error bars are reported as standard deviation (SD). i–n NAIP2 RGC-iNs from different genetic backgrounds differentiated and imaged in brightfield and POU4F2+ tdTomato fluorescence for clonally selected i, j IMR90.4 and k, l GM23720 PSCs, and m, n brightfield and POU4F2 + h2b-mNeonGreen fluorescence for WA09 PSCs. Click-iT EdU staining in o undifferentiated PSCs and 2-day LDN/dox treated p control, q NEUROG2, and r NAIP2 cells co-stained with DAPI. Arrows in O-R indicate EdU+ cells. Scale b–g, i–n = 100 µm, o–r = 200 µm.
Fig. 2 Enhancement of neuronal morphology after patterning by BMP inhibition. a Timeline of LDN193189 and/or dox treatments of POU4F2-tdTomato PSCs with an integrated empty cassette (control) or NAIP2 cassette (conditions 1–3). Brightfield images of dox treated b empty cassette control cells, c NAIP2-nc, d NEUROG2, e POU4F2, f ATOH7, and g ISLET1 cells after 6 days. NAIP2-nc = not clonally selected. h Quantification of %POU4F2+ cells at day 6 relative to DAPI in the empty cassette control and conditions 1–3 illustrated in (a). *P < 0.05, **P < 0.01, ***P < 0.001, ns P > 0.05, n = 3. Error bars are reported as standard deviation (SD). i–n NAIP2 RGC-iNs from different genetic backgrounds differentiated and imaged in brightfield and POU4F2+ tdTomato fluorescence for clonally selected i, j IMR90.4 and k, l GM23720 PSCs, and m, n brightfield and POU4F2 + h2b-mNeonGreen fluorescence for WA09 PSCs. Click-iT EdU staining in o undifferentiated PSCs and 2-day LDN/dox treated p control, q NEUROG2, and r NAIP2 cells co-stained with DAPI. Arrows in O-R indicate EdU+ cells. Scale b–g, i–n = 100 µm, o–r = 200 µm.CC BY · PubMed Central
Fig. 3 Quantification of POU4F2-tdTomato+ cells induced with different TF combinations. a–l Representative images of PSCs induced for 6 days with LDN/dox and different TFs alone (N, A, I, P2) or in combination (NAIP2, NA, NAI, AI, NP, NAP2, IP2) with imaging for DAPI (left) and POU4F2-tdTomato+ (right). TdTomato panels are intentionally uniformly overexposed so that samples with weaker fluorescence (d–l) could be detected. m Percent of POU4F2-tdTomato+ cells on day 6 quantified as POU4F2+ cells relative to DAPI. For the WA09 background, this was determined by measuring h2b-mNeonGreen+ relative to DAPI. n NAI iNs and o NAIP2 RGC-iNs showing POU4F2-tdTomato expression (left) and TUJ1 staining (right). NAI cells were additionally labeled with DAPI. p %TUJ1+ neurons and q %TUJ1+/POU4F2+ co-labeled RGC-iNs. r A diagram summarizing the key events driving differentiation from immature PSCs to mature RGCs. White arrows=overlapping tdTomato+ signal; yellow arrows=absence of a signal. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, ns P > 0.05, n = 3. Error bars are reported as standard deviation (SD). Scale a–l = 200 µm; n, o =100 µm.
Fig. 3 Quantification of POU4F2-tdTomato+ cells induced with different TF combinations. a–l Representative images of PSCs induced for 6 days with LDN/dox and different TFs alone (N, A, I, P2) or in combination (NAIP2, NA, NAI, AI, NP, NAP2, IP2) with imaging for DAPI (left) and POU4F2-tdTomato+ (right). TdTomato panels are intentionally uniformly overexposed so that samples with weaker fluorescence (d–l) could be detected. m Percent of POU4F2-tdTomato+ cells on day 6 quantified as POU4F2+ cells relative to DAPI. For the WA09 background, this was determined by measuring h2b-mNeonGreen+ relative to DAPI. n NAI iNs and o NAIP2 RGC-iNs showing POU4F2-tdTomato expression (left) and TUJ1 staining (right). NAI cells were additionally labeled with DAPI. p %TUJ1+ neurons and q %TUJ1+/POU4F2+ co-labeled RGC-iNs. r A diagram summarizing the key events driving differentiation from immature PSCs to mature RGCs. White arrows=overlapping tdTomato+ signal; yellow arrows=absence of a signal. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, ns P > 0.05, n = 3. Error bars are reported as standard deviation (SD). Scale a–l = 200 µm; n, o =100 µm.CC BY · PubMed Central
Fig. 4 Validation of RGC-iNs by RNA-seq. a Principal Component Analysis (PCA) plot of day 6 CTL, NAIP2 and PSC (top) and NEUROG2, NA, NAIP2-nc and NAIP2 cells (bottom). b Venn diagram of the number of genes expressed in each sample (normalized count >10). c Heatmap of the top 500 genes expressed in the NAIP2 samples. d Bar graph depicting −log10(FDR) of significantly differentially expressed pathways between NAIP2 and CTL samples identified by DAVID in Uniprot (top) and KEGG Gene Ontology (bottom) databases. e Scatterplots showing normalized counts of pan-neuronal and RGC marker genes in each treatment group. f Heatmaps of genes expressed within the neurogenesis (left), axon guidance (center), and growth factor (right) pathways. g Volcano plot highlighting log2(FC) gene expression between the CTL and NAIP2 samples plotted with respect to −log10(FDR). Immunostaining for VIM and GLAST in control cells (left) and PAX6, ISL1, POU4F1, and MAP2 in NAIP2 samples (right). FDR = false discovery rate. FC = fold change. Scale g = 85 µm. NAIP2-nc = RGC-iNs from non-clonally selected PSCs.
Fig. 4 Validation of RGC-iNs by RNA-seq. a Principal Component Analysis (PCA) plot of day 6 CTL, NAIP2 and PSC (top) and NEUROG2, NA, NAIP2-nc and NAIP2 cells (bottom). b Venn diagram of the number of genes expressed in each sample (normalized count >10). c Heatmap of the top 500 genes expressed in the NAIP2 samples. d Bar graph depicting −log10(FDR) of significantly differentially expressed pathways between NAIP2 and CTL samples identified by DAVID in Uniprot (top) and KEGG Gene Ontology (bottom) databases. e Scatterplots showing normalized counts of pan-neuronal and RGC marker genes in each treatment group. f Heatmaps of genes expressed within the neurogenesis (left), axon guidance (center), and growth factor (right) pathways. g Volcano plot highlighting log2(FC) gene expression between the CTL and NAIP2 samples plotted with respect to −log10(FDR). Immunostaining for VIM and GLAST in control cells (left) and PAX6, ISL1, POU4F1, and MAP2 in NAIP2 samples (right). FDR = false discovery rate. FC = fold change. Scale g = 85 µm. NAIP2-nc = RGC-iNs from non-clonally selected PSCs.CC BY · PubMed Central
Fig. 5 Temporal RNA-seq of RGC-iNs. a Timeline for longitudinal studies. b RNA-seq PCA plot showing clustering among PSCs, days 6, 14, 21, and 28 (D6, -14, -21, -28) RGC-iN cultures and days 6, 14, and 21 (D6, -14, -21) CTLs. c Venn Diagram showing overlapping genes at each time point (normalized count > 10). d POU4F1-mNeonGreen/POU4F2-tdTomato dual reporters in RGC-iNs at day 6. e Cryosectioned day 45 organoids exhibiting POU4F2-tdTomato + /POU4F1-mNeonGreen+ reporter expression. f Heatmap indicating the expression of selected markers for housekeeping (HKG), pluripotency, NAIP2 cassette, photoreceptor (PRs), glial, RGC, inhibitory, excitatory, and pan-neuronal genes. g Line graph showing the RGC transcription factors (TFs) NEUROG2, ATOH7, ISL1, POU4F1, and POU4F2 expression at each time point. h Line graph for selected neurotrophin receptors and immunostaining of day 6 RGC-iNs with pCREB after 30 min BDNF treatment. i Heatmap highlighting ion channel genes expressed at each time point. j UMAPs of RGC-iNs colored by time point (top) and Louvain clusters (bottom). k UMAPs of RGC-iNs colored by pan-neuronal marker gene expression (top) and RGC-specific marker genes (bottom). l Heatmap showing normalized expression of various RGC-subtype marker genes in each cluster of RGC-iNs across day 7, 14, and 21 time points. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, ns P > 0.05, n = 3 for PSCs, n = 4 for all other samples. Error bars g, h = SEM. Scale d = 50 µm, e = 200 µm, e, inset = 50 µm, h = 85 µm.
Fig. 5 Temporal RNA-seq of RGC-iNs. a Timeline for longitudinal studies. b RNA-seq PCA plot showing clustering among PSCs, days 6, 14, 21, and 28 (D6, -14, -21, -28) RGC-iN cultures and days 6, 14, and 21 (D6, -14, -21) CTLs. c Venn Diagram showing overlapping genes at each time point (normalized count > 10). d POU4F1-mNeonGreen/POU4F2-tdTomato dual reporters in RGC-iNs at day 6. e Cryosectioned day 45 organoids exhibiting POU4F2-tdTomato + /POU4F1-mNeonGreen+ reporter expression. f Heatmap indicating the expression of selected markers for housekeeping (HKG), pluripotency, NAIP2 cassette, photoreceptor (PRs), glial, RGC, inhibitory, excitatory, and pan-neuronal genes. g Line graph showing the RGC transcription factors (TFs) NEUROG2, ATOH7, ISL1, POU4F1, and POU4F2 expression at each time point. h Line graph for selected neurotrophin receptors and immunostaining of day 6 RGC-iNs with pCREB after 30 min BDNF treatment. i Heatmap highlighting ion channel genes expressed at each time point. j UMAPs of RGC-iNs colored by time point (top) and Louvain clusters (bottom). k UMAPs of RGC-iNs colored by pan-neuronal marker gene expression (top) and RGC-specific marker genes (bottom). l Heatmap showing normalized expression of various RGC-subtype marker genes in each cluster of RGC-iNs across day 7, 14, and 21 time points. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, ns P > 0.05, n = 3 for PSCs, n = 4 for all other samples. Error bars g, h = SEM. Scale d = 50 µm, e = 200 µm, e, inset = 50 µm, h = 85 µm.CC BY · PubMed Central
Fig. 6 Functional analysis of RGC-iNs. Day 14 (D14) RGC-iNs stained with a DAPI, TAU, and MAP2. b DAPI and TUJ1 overlayed with tdTomato. c Patched D14 RGC-iN. d Electrophysiological recordings from RGC-iNs under current clamp showing single action potentials elicited in response to depolarizing current injection as early as 14 days. By day 28, RGC-iNs are shown to exhibit repetitive action potentials. Resting membrane potential = −60 mV. Threshold current = 60 pA. e Under voltage clamp, depolarizing voltage steps in RGC-iNs reveal both fast inward Na+ and outward K+ currents, which are increased at day 28 compared to day 14. f, left: An example AMPA puff (1 mM) evoked current in a voltage-clamped RGC-iN. f, right: I–V plot for AMPA puff evoked currents in RGC-iN (solid symbols), and linear fit (solid line). Traces on the left show time course and double exponential fit to putative sEPSCs. g Example of current traces showing spontaneous excitatory post-synaptic currents (sEPSCs) that were blocked by the AMPA/Kainate antagonist DNQX. Scale a, b = 200 µm.
Fig. 6 Functional analysis of RGC-iNs. Day 14 (D14) RGC-iNs stained with a DAPI, TAU, and MAP2. b DAPI and TUJ1 overlayed with tdTomato. c Patched D14 RGC-iN. d Electrophysiological recordings from RGC-iNs under current clamp showing single action potentials elicited in response to depolarizing current injection as early as 14 days. By day 28, RGC-iNs are shown to exhibit repetitive action potentials. Resting membrane potential = −60 mV. Threshold current = 60 pA. e Under voltage clamp, depolarizing voltage steps in RGC-iNs reveal both fast inward Na+ and outward K+ currents, which are increased at day 28 compared to day 14. f, left: An example AMPA puff (1 mM) evoked current in a voltage-clamped RGC-iN. f, right: I–V plot for AMPA puff evoked currents in RGC-iN (solid symbols), and linear fit (solid line). Traces on the left show time course and double exponential fit to putative sEPSCs. g Example of current traces showing spontaneous excitatory post-synaptic currents (sEPSCs) that were blocked by the AMPA/Kainate antagonist DNQX. Scale a, b = 200 µm.CC BY · PubMed Central
Fig. 7 Inhibition of DLK/LZK and GCK-IV pathways protects against neuronal injury. a Diagram illustrating a model for blocking DLK-induced cell death. b Timeline for RGC-iN differentiation, colchicine-induced injury and neuroprotection with GNE-3511. c RGC-iNs treated with or without GNE-3511 (1 μM), 72 h after treatment with or without colchicine (40 nM). d Quantification of the CellTiterGlo (CTG) viability assay in the presence or absence of GNE-3511 in combination with increasing doses of colchicine (n = 4). e Timeline for RGC-iN differentiation, injury from paclitaxel(P), and neuroprotection with PF-06260933(PF). f Representative Calcein-AM images after treatment at D1, 2, 3, and 4 with control, paclitaxel, PF-06260933 and paclitaxel + PF-06260933. Quantification of viability using CTG in NAIP2 cells in g IMR90.4, h WA09, and i GM23720 RGC-iNs normalized relative to controls after treatment with P, PF or P + PF (n = 3). Scale c = 200 µm, f = 400 µm. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Error bars are reported as standard deviation (SD).
Fig. 7 Inhibition of DLK/LZK and GCK-IV pathways protects against neuronal injury. a Diagram illustrating a model for blocking DLK-induced cell death. b Timeline for RGC-iN differentiation, colchicine-induced injury and neuroprotection with GNE-3511. c RGC-iNs treated with or without GNE-3511 (1 μM), 72 h after treatment with or without colchicine (40 nM). d Quantification of the CellTiterGlo (CTG) viability assay in the presence or absence of GNE-3511 in combination with increasing doses of colchicine (n = 4). e Timeline for RGC-iN differentiation, injury from paclitaxel(P), and neuroprotection with PF-06260933(PF). f Representative Calcein-AM images after treatment at D1, 2, 3, and 4 with control, paclitaxel, PF-06260933 and paclitaxel + PF-06260933. Quantification of viability using CTG in NAIP2 cells in g IMR90.4, h WA09, and i GM23720 RGC-iNs normalized relative to controls after treatment with P, PF or P + PF (n = 3). Scale c = 200 µm, f = 400 µm. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Error bars are reported as standard deviation (SD).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 72

  1. Todd, L. et al. Reprogramming Muller glia to regenerate ganglion-like cells in adult mouse retina with developmental transcription factors. Sci. Adv. 8, eabq7219 (2022). · DOI
  2. Huang, J., Liu, Y., Oltean, A. & Beebe, D. C. Bmp4 from the optic vesicle specifies murine retina formation. Dev. Biol. 402, 119–126 (2015). · doi:10.1016/j.ydbio.2015.03.006
  3. Heavner, W. & Pevny, L. Eye development and retinogenesis. Cold Spring Harb. Perspect. Biol. 4, a008391–a008391 (2012). · DOI · Paper page
  4. Hasegawa, Y. et al. Emergence of dorsal-ventral polarity in ESC-derived retinal tissue. Development 143, 3895–3906 (2016). · DOI
  5. Hufnagel, R. B., Le, T. T., Riesenberg, A. L. & Brown, N. L. Neurog2 controls the leading edge of neurogenesis in the mammalian retina. Dev. Biol. 340, 490–503 (2010). · DOI
  6. Luo, Z. et al. Islet1 and Brn3 expression pattern study in human retina and hiPSC-derived retinal organoid. Stem Cells Int. 2019, 1–14 (2019). · DOI
  7. Parras, C. M. et al. Divergent functions of the proneural genes Mash1 and Ngn2 in the specification of neuronal subtype identity. Genes Dev. 16, 324–338 (2002). · DOI · Paper page
  8. Akagi, T. et al. Requirement of multiple basic helix-loop-helix genes for retinal neuronal subtype specification. J. Biol. Chem. 279, 28492–28498 (2004). · DOI
  9. Busskamp, V. et al. Rapid neurogenesis through transcriptional activation in human stem cells. Mol. Syst. Biol. 10, 760 (2014). · DOI · Paper page
  10. Nehme, R. et al. Combining NGN2 programming with developmental patterning generates human excitatory neurons with NMDAR-mediated synaptic transmission. Cell Rep. 23, 2509–2523 (2018). · DOI · Paper page
  11. Wang, J. et al. Quick commitment and efficient reprogramming route of direct induction of retinal ganglion cell-like neurons. Stem Cell Rep. 15, 1095–1110 (2020). · DOI
  12. Wu, F. et al. Two transcription factors, Pou4f2 and Isl1, are sufficient to specify the retinal ganglion cell fate. Proc. Natl Acad. Sci. USA 112, E1559–E1568 (2015). · DOI
  13. Mu, X., Fu, X., Beremand, P. D., Thomas, T. L. & Klein, W. H. Gene regulation logic in retinal ganglion cell development: Isl1 defines a critical branch distinct from but overlapping with Pou4f2. Proc. Natl Acad. Sci. USA 105, 6942–6947 (2008). · DOI · Paper page
  14. Pan, L., Deng, M., Xie, X. & Gan, L. ISL1 and BRN3B co-regulate the differentiation of murine retinal ganglion cells. Development 135, 1981–1990 (2008). · DOI · Paper page
  15. Xiao, D. et al. Directed Robust Generation of Functional Retinal Ganglion Cells from Müller Glia (Neuroscience, 2019). · DOI
  16. Chang, K.-C. & Hertz, J. SoxC transcription factors in retinal development and regeneration. Neural Regen. Res. 12, 1048 (2017). · doi:10.4103/1673-5374.211178
  17. Jiang, Y. et al. Transcription factors SOX4 and SOX11 function redundantly to regulate the development of mouse retinal ganglion cells. J. Biol. Chem. 288, 18429–18438 (2013). · DOI
  18. Sluch, V. M. et al. Enhanced stem cell differentiation and immunopurification of genome engineered human retinal ganglion cells. Stem Cells Transl. Med. 6, 1972–1986 (2017). · DOI · Paper page
  19. Vierbuchen, T. et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463, 1035–1041 (2010). · DOI · Paper page
  20. Ng, A. H. M. et al. A comprehensive library of human transcription factors for cell fate engineering. Nat. Biotechnol. 39, 510–519 (2021). · DOI · Paper page
  21. Cerbini, T. et al. Transcription activator-like effector nuclease (TALEN)-mediated CLYBL targeting enables enhanced transgene expression and one-step generation of dual reporter human induced pluripotent stem cell (iPSC) and neural stem cell (NSC) lines. PLoS ONE 10, e0116032 (2015). · DOI · Paper page
  22. Yan, W. et al. Cell atlas of the human fovea and peripheral retina. Sci. Rep. 10, 9802 (2020).
  23. Panza, P. et al. The LRR receptor Islr2 is required for retinal axon routing at the vertebrate optic chiasm. Neural Dev. 10, 23 (2015). · DOI
  24. Hocking, J. C., Hehr, C. L., Bertolesi, G. E., Wu, J. Y. & McFarlane, S. Distinct roles for Robo2 in the regulation of axon and dendrite growth by retinal ganglion cells. Mech. Dev. 127, 36–48 (2010). · DOI
  25. Assou, S. et al. A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas. Stem Cells 25, 961–973 (2007). · DOI · Paper page
  26. Bernard, F. et al. Role of transmembrane semaphorin Sema6A in oligodendrocyte differentiation and myelination. Glia 60, 1590–1604 (2012). · DOI · Paper page
  27. Chambers, S. M. et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 27, 275–280 (2009). · DOI · Paper page
  28. Zhou, S. et al. Neurosphere based differentiation of human iPSC improves astrocyte differentiation. Stem Cells Int. 2016, 4937689 (2016). · DOI · Paper page
  29. de Melo, J. et al. Lhx2 is an essential factor for retinal gliogenesis and notch signaling. J. Neurosci. 36, 2391–2405 (2016). · DOI
  30. Wahlin, K. J., Campochiaro, P. A., Zack, D. J. & Adler, R. Neurotrophic factors cause activation of intracellular signaling pathways in Muller cells and other cells of the inner retina, but not photoreceptors. Investig. Ophthalmol. Vis. Sci. 41, 927–936 (2000).
  31. Huang, E. J. & Reichardt, L. F. Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 24, 677–736 (2001). · DOI · Paper page
  32. Zhong, Y. S., Wang, J., Liu, W. M. & Zhu, Y. H. Potassium ion channels in retinal ganglion cells (review). Mol. Med. Rep. 8, 311–319 (2013). · DOI
  33. Van Hook, M. J., Nawy, S. & Thoreson, W. B. Voltage- and calcium-gated ion channels of neurons in the vertebrate retina. Prog. Retin. Eye Res. 72, 100760 (2019). · DOI
  34. Dhande, O. S., Stafford, B. K., Lim, J. A. & Huberman, A. D. Contributions of retinal ganglion cells to subcortical visual processing and behaviors. Annu. Rev. Vis. Sci. 1, 291–328 (2015). · DOI · Paper page
  35. Langer, K. B. et al. Retinal ganglion cell diversity and subtype specification from human pluripotent stem cells. Stem Cell Rep. 10, 1282–1293 (2018). · DOI · Paper page
  36. Lu, Y. et al. Single-cell analysis of human retina identifies evolutionarily conserved and species-specific mechanisms controlling development. Dev. Cell 53, 473–491 e479 (2020). · DOI · Paper page
  37. Sridhar, A. et al. Single-cell transcriptomic comparison of human fetal retina, hPSC-derived retinal organoids, and long-term retinal cultures. Cell Rep. 30, 1644–1659 e1644 (2020). · DOI · Paper page
  38. Gudiseva, H. V. et al. Single cell sequencing of induced pluripotent stem cell derived retinal ganglion cells (iPSC-RGC) reveals distinct molecular signatures and RGC subtypes. Genes 12, 2015 (2021). · DOI
  39. Orozco, L. D. et al. Integration of eQTL and a single-cell atlas in the human eye identifies causal genes for age-related macular degeneration. Cell Rep. 30, 1246–1259 e1246 (2020). · DOI · Paper page
  40. Liang, Q. et al. A multi-omics atlas of the human retina at single-cell resolution. Cell Genom. 3, 100298 (2023). · DOI
  41. Bounoutas, A. et al. Microtubule depolymerization in Caenorhabditis elegans touch receptor neurons reduces gene expression through a p38 MAPK pathway. Proc. Natl Acad. Sci. USA 108, 3982–3987 (2011). · DOI
  42. Valakh, V., Frey, E., Babetto, E., Walker, L. J. & DiAntonio, A. Cytoskeletal disruption activates the DLK/JNK pathway, which promotes axonal regeneration and mimics a preconditioning injury. Neurobiol. Dis. 77, 13–25 (2015). · DOI
  43. Saikia, J. M. et al. A critical role for DLK and LZK in axonal repair in the mammalian spinal cord. J. Neurosci. 42, 3716–3732 (2022). · DOI
  44. Shin, J. E., Ha, H., Kim, Y. K., Cho, Y. & DiAntonio, A. DLK regulates a distinctive transcriptional regeneration program after peripheral nerve injury. Neurobiol. Dis. 127, 178–192 (2019). · DOI
  45. Patel, A. K. et al. Inhibition of GCK-IV kinases dissociates cell death and axon regeneration in CNS neurons. Proc. Natl Acad. Sci. USA 117, 33597–33607 (2020). · DOI
  46. Welsbie, D. S. et al. Enhanced functional genomic screening identifies novel mediators of dual leucine zipper kinase-dependent injury signaling in neurons. Neuron 94, 1142 (2017). · DOI · Paper page
  47. Welsbie, D. S. et al. Functional genomic screening identifies dual leucine zipper kinase as a key mediator of retinal ganglion cell death. Proc. Natl Acad. Sci. USA 110, 4045–4050 (2013). · DOI · Paper page
  48. Judson, R. L., Babiarz, J. E., Venere, M. & Blelloch, R. Embryonic stem cell-specific microRNAs promote induced pluripotency. Nat. Biotechnol. 27, 459–461 (2009). · DOI · Paper page
  49. Zhang, X. et al. Single cell transcriptomic analyses reveal the impact of bHLH factors on human retinal organoid development. Front Cell Dev. Biol. 9, 653305 (2021). · DOI
  50. Zhang, X.-M., Hashimoto, T., Tang, R. & Yang, X.-J. Elevated expression of human bHLH factor ATOH7 accelerates cell cycle progression of progenitors and enhances production of avian retinal ganglion cells. Sci. Rep. 8, 6823 (2018).
  51. Chen, M. et al. Generation of retinal ganglion-like cells from reprogrammed mouse fibroblasts. Investig. Ophthalmol. Vis. Sci. 51, 5970–5978 (2010). · DOI
  52. Meng, F., Wang, X., Gu, P., Wang, Z. & Guo, W. Induction of retinal ganglion-like cells from fibroblasts by adenoviral gene delivery. Neuroscience 250, 381–393 (2013). · DOI
  53. Luo, Z. et al. Directly induced human retinal ganglion cells mimic fetal RGCs and are neuroprotective after transplantation in vivo. Stem Cell Rep. 17, 2690–2703 (2022). · DOI
  54. Ohlemacher, S. K. et al. Stepwise differentiation of retinal ganglion cells from human pluripotent stem cells enables analysis of glaucomatous neurodegeneration. Stem Cells 34, 1553–1562 (2016). · DOI · Paper page
  55. Ji, S.-L. & Tang, S.-B. Differentiation of retinal ganglion cells from induced pluripotent stem cells: a review. Int. J. Ophthalmol. 12, 152–160 (2019).
  56. Teotia, P. et al. Generation of functional human retinal ganglion cells with target specificity from pluripotent stem cells by chemically defined recapitulation of developmental mechanism. Stem Cells 35, 572–585 (2017). · DOI
  57. Sanes, J. R. & Masland, R. H. The types of retinal ganglion cells: current status and implications for neuronal classification. Annu. Rev. Neurosci. 38, 221–246 (2015). · DOI · Paper page
  58. Hahn, J. et al. Evolution of neuronal cell classes and types in the vertebrate retina. Preprint at bioRxiv https://doi.org/10.1101/2023.04.07.536039 (2023). · DOI
  59. Wahlin, K. J. et al. Photoreceptor outer segment-like structures in long-term 3D retinas from human pluripotent stem cells. Sci. Rep. 7, 766 (2017). · DOI · Paper page
  60. Wahlin, K. J. et al. CRISPR generated SIX6 and POU4F2 reporters allow identification of brain and optic transcriptional differences in human PSC-derived organoids. Front. Cell Dev. Biol. 9, 764725 (2021). · DOI
  61. Kleinstiver, B. P. et al. Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing. Nat. Biotechnol. 37, 276–282 (2019). · DOI · Paper page
  62. Gossen, M. et al. Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766–1769 (1995). · DOI · Paper page
  63. Fligor, C. M., Huang, K. C., Lavekar, S. S., VanderWall, K. B. & Meyer, J. S. Differentiation of retinal organoids from human pluripotent stem cells. Methods Cell Biol. 159, 279–302 (2020). · DOI
  64. Brewer, G. J., Torricelli, J. R., Evege, E. K. & Price, P. J. Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35, 567–576 (1993). · DOI · Paper page
  65. Bardy, C. et al. Neuronal medium that supports basic synaptic functions and activity of human neurons in vitro. Proc. Natl Acad. Sci. USA 112, E2725–E2734 (2015). · DOI · Paper page
  66. Bae, D. et al. Hypoxia enhances the generation of retinal progenitor cells from human induced pluripotent and embryonic stem cells. Stem Cells Dev. 21, 1344–1355 (2012). · DOI
  67. Garita-Hernandez, M. et al. Hypoxia increases the yield of photoreceptors differentiating from mouse embryonic stem cells and improves the modeling of retinogenesis in vitro. Stem Cells 31, 966–978 (2013). · DOI
  68. Gavrilovici, C., Pollock, E., Everest, M. & Poulter, M. O. The loss of interneuron functional diversity in the piriform cortex after induction of experimental epilepsy. Neurobiol. Dis. 48, 317–328 (2012). · DOI
  69. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013). · DOI · Paper page
  70. Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).
  71. Blondel, V. D., Guillaume, J.-L., Lambiotte, R. & Lefebvre, E. Fast unfolding of communities in large networks. J. Stat. Mech.: Theory Exp. 2008, P10008 (2008). · DOI · Paper page
  72. Hie, B., Bryson, B. & Berger, B. Efficient integration of heterogeneous single-cell transcriptomes using Scanorama. Nat. Biotechnol. 37, 685–691 (2019). · DOI · Paper page

Cited by

See all 21

Metadata

Authors
Agarwal, D., Dash, N., Mazo, K. W., Chopra, M., Avila, M. P., Patel, A., Wong, R. M., Jia, C., Do, H., Cheng, J., Chiang, C., Jurlina, S. L., Roshan, M., Perry, M. W., Rho, J. M., Broyer, R., Lee, C. D., Weinreb, R. N., Gavrilovici, C., Oesch, N. W., Welsbie, D. S., & Wahlin, K. J.
Venue
npj Regenerative Medicine
Published
2023-09-29
Volume
8
Issue
1
ISSN
2057-3995
Cited by
21
References
9
Language
en
Licence
Funders
  • U.S. Department of Health & Human Services | NIH | National Eye Institute (K99/R00EY024648, R01EY031318, R21EY031122, P30EY022589, R01EY031714, R01EY029342)
  • Foundation Fighting Blindness
  • Research to Prevent Blindness
  • BrightFocus Foundation
  • California Institute for Regenerative Medicine (DISC1-08683)
  • U.S. Department of Health & Human Services | National Institutes of Health (S10OD026929)
  • Michael Luzich in honor of Norman and Carol Luzich for providing generous funding for this work.
  • Glaucoma Research Foundation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human retinal ganglion cell neurons generated by synchronous BMP inhibition and transcription factor mediated reprogramming. https://app.cochat.ai/papers/10.1038/s41536-023-00327-x
The paper
Agarwal, D., Dash, N., Mazo, K. W., Chopra, M., Avila, M. P., Patel, A., Wong, R. M., Jia, C., Do, H., Cheng, J., Chiang, C., Jurlina, S. L., Roshan, M., Perry, M. W., Rho, J. M., Broyer, R., Lee, C. D., Weinreb, R. N., Gavrilovici, C., . . . Wahlin, K. J. (2023). Human retinal ganglion cell neurons generated by synchronous BMP inhibition and transcription factor mediated reprogramming. npj Regenerative Medicine. https://doi.org/10.1038/s41536-023-00327-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.